Active, not recruitingPhase 2NCT04551170
Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old
Studying Albright hereditary osteodystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vanderbilt University Medical Center
- Principal Investigator
- Ashley Shoemaker, MDVanderbilt University Medical Center
- Intervention
- Theophylline(drug)
- Enrollment
- 34 enrolled
- Eligibility
- 2-12 years · All sexes
- Timeline
- 2020 – 2026
Study locations (1)
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04551170 on ClinicalTrials.govOther trials for Albright hereditary osteodystrophy
Additional recruiting or active studies for the same condition.